Jesse Goodman serves as Executive at Intellia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jesse Goodman has executed 6 insider transactions totaling $29.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 1, 2025 involved selling 1,547 shares valued at $14.3K.
Jesse Goodman currently holds 24,359 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jesse Goodman has been a net seller of NTLA stock. They have purchased $0 and sold $29.1K worth of shares.
Jesse Goodman's most recent insider trade was on Jul 1, 2025, when they sold 1,547 shares at $9.23 per share.
Get notified when new Form 4 filings are submitted
| $9.56 |
| Discretionary |
| Jun 12, 2024 | NTLA | $0 | Award | 7,737 | $N/A | Discretionary |
| Jun 14, 2023 | NTLA | $0 | Award | 4,425 | $N/A | Discretionary |
| Jun 14, 2022 | NTLA | $0 | Award | 5,197 | $N/A | Discretionary |
| Jun 23, 2021 | NTLA | $0 | Award | 2,094 | $N/A | Discretionary |